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MM and RDA conceived and designed the study; RV developed the eCRF; PM submitted the study to the Ethical Committee; VC wrote the full protocol; PV coordinated the project group. All the Authors contributed to develop the study protocol. The author(s) read and approved the final manuscript.
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The study data will be collected during the entire study period in a dedicated electronic Case Report Form (eCRF) provided by the Steering Committee (SC). Data will be collected and stored on the hospital server, which will be protected by password to prevent unintentional modification or deletion.

Approved by Comitato Etico Dell'istituto Nazionale per le Malattie Infettive "Lazzaro Spallanzani", Rome, Italy, on 21/05/2020; reference number of the ethical approval judgement 124/2020.
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The Investigator at each Centre will ensure that the subject is given full and adequate oral and written information about the nature, purpose, possible risks and benefits of the study. Subjects must also be notified that they are free to discontinue from the study at any time. The subject's signed and dated informed consent must be obtained prior to conduct any procedure specific for the study. The original signed Written Informed Consent Form must be stored, and a copy must be given to the patient.
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